Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
LANCET HEALTHY LONGEVITY
Journal
Overview
Identity
Other
View All
Overview
publication venue for
Cardiorenal outcomes, kidney function, and other safety outcomes with ertugliflozin in older adults with type 2 diabetes (VERTIS CV): secondary analyses from a randomised, double-blind trial
. 4:E143-E154.
2023
Closed-loop therapy in older adults with type 1 diabetes: hypoglycaemia benefits and risk stratification
2022
Can technology improve the management of older adults with type 1 diabetes? Yes, but... Comment
2022
Identity
International Standard Serial Number (ISSN)
2666-7568
Other
journal abbreviation
LANCET HEALTH LONGEV